MX2021000184A - Anticuerpos contra agentes patogenos en aves de corral y sus aplicaciones. - Google Patents

Anticuerpos contra agentes patogenos en aves de corral y sus aplicaciones.

Info

Publication number
MX2021000184A
MX2021000184A MX2021000184A MX2021000184A MX2021000184A MX 2021000184 A MX2021000184 A MX 2021000184A MX 2021000184 A MX2021000184 A MX 2021000184A MX 2021000184 A MX2021000184 A MX 2021000184A MX 2021000184 A MX2021000184 A MX 2021000184A
Authority
MX
Mexico
Prior art keywords
poultry
antibodies against
disease causing
against disease
causing agents
Prior art date
Application number
MX2021000184A
Other languages
English (en)
Inventor
Hamlet Abnousi
Slade Andrew Loutet
Petegem Filip Louis Arsene Van
Tsz Ying Sylvia Cheung
Original Assignee
Novobind Livestock Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novobind Livestock Therapeutics Inc filed Critical Novobind Livestock Therapeutics Inc
Publication of MX2021000184A publication Critical patent/MX2021000184A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describen aquí los métodos y anticuerpos útiles para reducir, eliminar o prevenir la infección con una población bacteriana en un animal. También se describen aquí los antígenos útiles para atacar y reducir una población bacteriana en un animal empleando anticuerpos de cadena pesada y fragmentos VHH.
MX2021000184A 2018-07-05 2019-07-03 Anticuerpos contra agentes patogenos en aves de corral y sus aplicaciones. MX2021000184A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862694164P 2018-07-05 2018-07-05
PCT/IB2019/001198 WO2020035741A2 (en) 2018-07-05 2019-07-03 Antibodies against disease causing agents of poultry and uses thereof

Publications (1)

Publication Number Publication Date
MX2021000184A true MX2021000184A (es) 2021-05-12

Family

ID=69525293

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021000184A MX2021000184A (es) 2018-07-05 2019-07-03 Anticuerpos contra agentes patogenos en aves de corral y sus aplicaciones.

Country Status (9)

Country Link
US (1) US20210269512A1 (es)
EP (1) EP3818079A4 (es)
CN (1) CN112703201A (es)
BR (1) BR112021000100A2 (es)
CA (1) CA3103656A1 (es)
IL (1) IL279879A (es)
MX (1) MX2021000184A (es)
PH (1) PH12021550025A1 (es)
WO (1) WO2020035741A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201202319D0 (en) 2012-02-10 2012-03-28 Orbsen Therapeutics Ltd Stromal stem cells
EP3271396B1 (en) 2015-03-20 2022-03-16 Orbsen Therapeutics Limited Modulators of syndecan-2 and uses thereof
EP3922253A1 (en) 2016-01-15 2021-12-15 Orbsen Therapeutics Limited Sdc-2 exosome compositions and methods of isolation and use
US11130800B2 (en) 2016-05-20 2021-09-28 Novobind Livestock Therapeutics Inc. Antibodies against microorganisms and uses thereof
BR112019025019A2 (pt) * 2017-05-31 2020-06-30 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food polipeptídeo isolado de pilus de clostridium perfringens, polipeptídeo imunogênico, vetor, vacina, uso de um polipeptídeo imunogênico, método de tratamento, anticorpo, método para detectar infecção e método para detectar um polipeptídeo imunogênico
EP3652305A2 (en) 2017-07-14 2020-05-20 Orbsen Therapeutics Limited Cd39 stromal stem cells methods of isolation and use
GB202207698D0 (en) * 2022-05-25 2022-07-06 Eco Animal Health Ltd Antibodies
WO2024089627A1 (en) * 2022-10-26 2024-05-02 Berking Biotechnology Spa Single domain antibody - sdab/vhh against the nucleoprotein of sars-cov-2 virus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2164862B1 (en) * 2007-06-08 2015-07-22 Australian Poultry CRC Pty Ltd Clostridial toxin netb
CA2874191A1 (en) * 2012-05-23 2013-11-28 University Of Guelph A novel toxin in type a clostridium perfringens
WO2015156673A1 (en) * 2014-04-10 2015-10-15 Stichting Vu-Vumc IMMUNOGLOBULINS BINDING HUMAN Vγ9Vδ2 T CELL RECEPTORS
WO2018035407A1 (en) * 2016-08-19 2018-02-22 Enbiotix, Inc. Bacteriophages for neutralizing toxins and methods of use thereof
MX2021009398A (es) * 2019-02-05 2021-11-17 Elanco Us Inc Composiciones probioticas que comprenden cepas de lactobacillus reuteri y metodos de uso.

Also Published As

Publication number Publication date
US20210269512A1 (en) 2021-09-02
WO2020035741A2 (en) 2020-02-20
CA3103656A1 (en) 2020-02-20
PH12021550025A1 (en) 2021-09-27
IL279879A (en) 2021-03-01
EP3818079A4 (en) 2022-04-06
EP3818079A2 (en) 2021-05-12
CN112703201A (zh) 2021-04-23
WO2020035741A3 (en) 2020-05-07
BR112021000100A2 (pt) 2021-03-30

Similar Documents

Publication Publication Date Title
PH12021550025A1 (en) Antibodies against disease causing agents of poultry and uses thereof
MX2020013248A (es) Anticuerpos contra agentes patogenos en acuacultura y sus aplicaciones.
MX2021014236A (es) Anticuerpos contra agentes patogenos de las aves de corral y usos de estos.
CL2020001575A1 (es) Anticuerpos anti-trem2 y métodos relacionados.
MX2020013169A (es) Conjugados de camptotecina.
CY1124488T1 (el) Απελευθερωση πρωτεϊνης που βασιζεται σε εξασθενημενης λοιμογονικοτητας βακτηριδια
EP4257199A3 (en) Humanized anti-human-pd-1 antibody
DOP2020000245A (es) Anticuerpos il-11
MX2021006681A (es) Anticuerpos anti-claudina y usos de los mismos.
EA201992546A1 (ru) Средства на основе антител к cd33
PH12020551716A1 (en) Anti-ror antibody constructs
PH12020500576A1 (en) Method of treating cancers with antagonistic anti-pd-1 antibodies
MX2021003654A (es) Metodo para seleccionar neoepitopes.
MX2020001574A (es) Sistemas y metodos para el control de la enfermedad de necrosis hepatopancreatica aguda.
MX2021005424A (es) Formas cristalinas de un compuesto de imidazopiridina sustituida y uso del mismo como modulador del receptor p2x3.
MX2021012692A (es) Anticuerpos anti-mertk y sus metodos de uso.
CR20220329A (es) Anticuerpos anti–mertk y metodos de uso de los mismos
EA201892525A1 (ru) Конструкции днк-антител для применения против pseudomonas aeruginosa
MX2021008216A (es) Anticuerpos anti-tigit.
ZA202205927B (en) Anti-yellow fever virus antibodies, and methods of their generation and use
EP3880701A4 (en) ANTIBODIES AGAINST CANID AND FELID PATHOGENS AND THEIR USE
MX2022006073A (es) Metodos para utilizar anticuerpos anti-trem2.
CL2023001052A1 (es) Composiciones y métodos para el tratamiento de la enfermedad ocular tiroidea
MX2020011027A (es) Constructos de anticuerpos biespecíficos trivalentes.
EP4295903A3 (en) Compositions and methods for treating farber disease